---
figid: PMC6230982__fonc-08-00500-g0002
figlink: /pmc/articles/PMC6230982/figure/F2/
number: F2
caption: Metabolic pathways involved in anticancer drug resistance in multiple myeloma
  (A), lung- and ovarian cancer (B), breast cancer (C), and melanoma (D). Metabolic
  enzymes that are associated with drug resistance are shown in purple. Metabolic
  inhibitors that can be used to target drug-resistant cancers are depicted in red.
  2-DG, 2-deoxyglucose; 2ME, 2-methoxyestradiol; 6-AN, 6-aminonicotinamide; ATP, adenosine
  triphosphate; BPTES, bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide;
  BSO, buthionine sulphoximine; FASN, fatty acid synthase; G6PDH, glucose-6-phosphate
  dehydrogenase; GCLC, glutamate-cysteine ligase; GLS, glutaminase; HK2, hexokinase
  2; I, complex I; II, complex II; III, complex III; IV, complex IV; LDHA, lactate
  dehydrogenase A; LDHB, lactate dehydrogenase B; mTOR, mammalian target of rapamycin;
  NQO1, NAD(P)H quinone dehydrogenase; PDH, pyruvate dehydrogenase complex; PDK1,
  pyruvate dehydrogenase kinase 1; PHGDH, 3-phosphoglycerate dehydrogenase; PPP, pentose
  phosphate pathway; R5P, ribose 5-phosphate; ROS, reactive oxygen species; SOD2,
  superoxide dismutase 2; SSP, serine synthesis pathway; TCA, tricarboxylic acid cycle;
  V, complex V; xCT, glutamate/cysteine xCT antiporter.
pmcid: PMC6230982
papertitle: The Influence of Metabolism on Drug Response in Cancer.
reftext: Esther A. Zaal, et al. Front Oncol. 2018;8:500.
pmc_ranked_result_index: '412'
pathway_score: 0.9471678
filename: fonc-08-00500-g0002.jpg
figtitle: Metabolic pathways involved in anticancer drug resistance
year: '2018'
organisms:
- Homo sapiens
ndex: 24ab90f5-debd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6230982__fonc-08-00500-g0002.html
  '@type': Dataset
  description: Metabolic pathways involved in anticancer drug resistance in multiple
    myeloma (A), lung- and ovarian cancer (B), breast cancer (C), and melanoma (D).
    Metabolic enzymes that are associated with drug resistance are shown in purple.
    Metabolic inhibitors that can be used to target drug-resistant cancers are depicted
    in red. 2-DG, 2-deoxyglucose; 2ME, 2-methoxyestradiol; 6-AN, 6-aminonicotinamide;
    ATP, adenosine triphosphate; BPTES, bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl
    sulfide; BSO, buthionine sulphoximine; FASN, fatty acid synthase; G6PDH, glucose-6-phosphate
    dehydrogenase; GCLC, glutamate-cysteine ligase; GLS, glutaminase; HK2, hexokinase
    2; I, complex I; II, complex II; III, complex III; IV, complex IV; LDHA, lactate
    dehydrogenase A; LDHB, lactate dehydrogenase B; mTOR, mammalian target of rapamycin;
    NQO1, NAD(P)H quinone dehydrogenase; PDH, pyruvate dehydrogenase complex; PDK1,
    pyruvate dehydrogenase kinase 1; PHGDH, 3-phosphoglycerate dehydrogenase; PPP,
    pentose phosphate pathway; R5P, ribose 5-phosphate; ROS, reactive oxygen species;
    SOD2, superoxide dismutase 2; SSP, serine synthesis pathway; TCA, tricarboxylic
    acid cycle; V, complex V; xCT, glutamate/cysteine xCT antiporter.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FASN
  - GCLC
  - GLS
  - HK2
  - LDHA
  - LDHB
  - SOD2
  - DLD
  - PDHA1
  - ESRRA
  - BRAF
  - PDHA2
  - PDHB
  - PDHX
  - PDK3
  - MTOR
  - DLAT
  - PDK1
  - PHGDH
  - SLC7A11
  - PDK4
  - PDK2
  - Cisplatin
  - Glucose
  - Serine
  - Pyruvate
  - DCA
  - Lactate
  - Glutathione
  - Acetyl-CoA
  - Mevalonate
  - Riluzole
  - Simvastatin
  - Cystine
  - Glutamate
  - TCA
  - Glutamine
  - Dicoumarol
  - BSO
  - Orlistat
  - Fatty Acids
  - O Glutamine
  - ATP
  - myeloma
  - ovarian cancer
  - breast cancer
  - melanoma
genes:
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: GCLC
  symbol: GCLC
  source: hgnc_symbol
  hgnc_symbol: GCLC
  entrez: '2729'
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: HK2
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: LDHB
  symbol: LDHB
  source: hgnc_symbol
  hgnc_symbol: LDHB
  entrez: '3945'
- word: (SOD2
  symbol: SOD2
  source: hgnc_symbol
  hgnc_symbol: SOD2
  entrez: '6648'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: ERRa
  symbol: ERRa
  source: hgnc_alias_symbol
  hgnc_symbol: ESRRA
  entrez: '2101'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PHGDH
  symbol: PHGDH
  source: hgnc_symbol
  hgnc_symbol: PHGDH
  entrez: '26227'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: xCT
  symbol: xCT
  source: hgnc_alias_symbol
  hgnc_symbol: SLC7A11
  entrez: '23657'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Glucose
  source: MESH
  identifier: D005947
- word: Serine
  source: MESH
  identifier: C047902
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: DCA
  source: MESH
  identifier: C048628
- word: Lactate
  source: MESH
  identifier: D019344
- word: Glutathione
  source: MESH
  identifier: D005978
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: Riluzole
  source: MESH
  identifier: D019782
- word: Simvastatin
  source: MESH
  identifier: D019821
- word: Cystine
  source: MESH
  identifier: D003553
- word: Glutamate
  source: ''
  identifier: ''
- word: TCA
  source: MESH
  identifier: C000589078
- word: Glutamine
  source: MESH
  identifier: C578860
- word: Dicoumarol
  source: MESH
  identifier: D001728
- word: BSO
  source: MESH
  identifier: C065566
- word: Orlistat
  source: MESH
  identifier: C055122
- word: Fatty Acids
  source: MESH
  identifier: D005227
- word: O Glutamine
  source: MESH
  identifier: C578860
- word: ATP
  source: MESH
  identifier: D000255
diseases:
- word: myeloma
  source: MESH
  identifier: D009101
- word: ovarian cancer
  source: MESH
  identifier: D010051
- word: breast cancer
  source: MESH
  identifier: D001943
- word: melanoma
  source: MESH
  identifier: D008545
figid_alias: PMC6230982__F2
redirect_from: /figures/PMC6230982__F2
figtype: Figure
---
